moderna mrna vaccine - Search News

Moderna, RSV

UK health regulator approves Moderna's RSV vaccine for adults aged 60 and older

Britain's health regulator said on Friday it has approved Moderna's vaccine for respiratory syncytial virus in adults 60 years and older.

Business Insider · 8h

Moderna receives MHRA marketing authorization for RSV vaccine

Moderna (MRNA) announced that the Medicines and Healthcare products Regulatory Agency in the UK has granted marketing authorization for

YAHOO!Finance · 8h

Moderna Receives Medicines and Healthcare Products Regulatory Agency Marketing Authorization in the UK for RSV Vaccine

RESVIA ®is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 /Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted

Vietnam Investment Review on M… · 1d

AIM Vaccine s mRNA RSV Vaccine Approved for U S Clinical Trials

Innovation and Global Expansion Attract Capital Reassessment AIM Vaccine Co., Ltd. (a joint stock company incorporated in the People's Republic of China with limited liability) (Stock Code: 6660.HK) HONG KONG,

Moderna, Trump and Flu Vaccine

Dailymotion on MSN · 3h

Trump Officials Review Biden-Era Funding For Moderna Bird Flu Vaccine Contract

US health officials are reviewing a nearly $600 million contract awarded to Moderna for bird flu vaccines in the final days of the Biden administration. The evaluation is part of a broader effort to reassess spending on mRNA-based vaccines,

Business Insider · 1d

Trump Team May Block Moderna’s (MRNA) Bird Flu Vaccine Funding

American pharmaceutical company Moderna (MRNA) is reportedly under scrutiny by U.S. President Donald Trump’s team, which is considering

Hosted on MSN · 1d

Funding for Moderna bird flu vaccine under review

The Trump administration confirmed it's reviewing whether to pull $590 million in funding that Moderna received in the final days of the Biden administration to develop an mRNA vaccine for bird flu in people.

Can Moderna's Aggressive Cost Cuts Help Turn Things Around for Its Stock?

Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future. One way Moderna has been trying to appease investors and reduce its losses ...

Newsable Asianet News on MSN15h

Moderna Stock Heads For Weekly Loss As Retail Caution Prevails: Wealth Advisor Tells Why She's Staying On The Sidelines

Shares of Moderna Inc. (MRNA) are on track for a more than 12% weekly decline, with sentiment among retail traders turning ...

2don MSN

Moderna, Inc. (MRNA): A Bull Case Theory

We came across a bullish thesis on Moderna, Inc. (MRNA) on wallstreetbets Subreddit Page by YouAlwaysHaveAChoice. In this ...

Rolling Out5d

What to know about the latest vaccine updates

COVID-19 vaccines target emerging variants, offering improved protection. Learn about their effectiveness, timing, and safety ...

Moderna to Present at Upcoming Conferences in March 2025

CAMBRIDGE, MA / ACCESS Newswire / February 25, 2025 / Moderna, Inc. (Nasdaq: MRNA), today announced its participation in the ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results